Alpha-linolenic acid: An omega-3 fatty acid with neuroprotective properties - Ready for use in the stroke clinic?

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Blondeau, Nicolas ^a   Lipsky, Robert H ^b   Bourourou, Miled ^a   Duncan, Mark W ^c,d   Gorelick, Philip B ^e   Marini, Ann M ^f  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LINOLENIC ACID; NEUROPROTECTIVE AGENT; OMEGA 3 FATTY ACID;

CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHEMICAL STRUCTURE; DEPRESSION; HOSPITAL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NEUROPROTECTION; NONHUMAN; PREVENTION; REVIEW; RODENT MODEL; ANIMAL; BRAIN; HUMAN; METABOLISM; STROKE;

RODENTIA;

ALPHA-LINOLENIC ACID; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FATTY ACIDS, OMEGA-3; HUMANS; NEUROPROTECTIVE AGENTS; STROKE;

EID: 84924362470     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/519830     Document Type: Review

References (99)

1. N. Blondeau and J. S. Tauskela, "A new future in brain preconditioning based on nutraceuticals: a focus on a-linolenic omega-3 fatty acid for stroke protection, " in Innate Tolerance in the CNS, J. M. Gidday, M. A. Perez-Pinzon, and J. H. Zhang, Eds., Springer Series in Translational Stroke Research, pp. 133-163, Springer, New York, NY, USA, 2013.
2. C. Nguemeni, B. Delplanque, C. Rovère et al., "Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke, " Pharmacological Research, vol. 61, no. 3, pp. 226-233, 2010.
3. C. Nguemeni, E. Gouix, M. Bourourou, C. Heurteaux, and N. Blondeau, "Alpha-linolenic acid: a promising nutraceutical for the prevention of stroke, " Pharma Nutrition, vol. 1, no. 1, pp. 1-8, 2013.
4. A. P. Simopoulos, "The importance of the omega-6/omega- 3 fatty acid ratio in cardiovascular disease and other chronic diseases, " Experimental Biology andMedicine, vol. 233, no. 6, pp. 674-688, 2008.
5. S. Basiouni, K. Stöckel, H. Fuhrmann, and J. Schumann, "Polyunsaturated fatty acid supplements modulate mast cell membrane microdomain composition, " Cellular Immunology, vol. 275, no. 1-2, pp. 42-46, 2012.
6. K. Simons and D. Toomre, "Lipid rafts and signal transduction, " Nature Reviews Molecular Cell Biology, vol. 1, no. 1, pp. 31-39, 2000.
7. G. Zhao, T. D. Etherton, K. R. Martin, P. J. Gillies, S. G. West, and P. M. Kris-Etherton, "Dietary α-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects, " The American Journal of Clinical Nutrition, vol. 85, no. 2, pp. 385-391, 2007.
8. T. Mutoh, T. Hamano, A. Tokuda, and M. Kuriyama, "Unglycosylated Trk protein does not co-localize nor associate with ganglioside GM1in stable clone of PC12 cells overexpressing Trk (PCtrk cells), " Glycoconjugate Journal, vol. 17, no. 3-4, pp. 233-237, 2000.
9. T. Golub, S. Wacha, and P. Caroni, "Spatial and temporal control of signaling through lipid rafts, " Current Opinion in Neurobiology, vol. 14, no. 5, pp. 542-550, 2004.
10. S. Besshoh, S. Chen, I. R. Brown, and J. W. Gurd, "Developmental changes in the association of NMDA receptors with lipid rafts, " Journal of Neuroscience Research, vol. 85, no. 9, pp. 1876-1883, 2007.
11. N. Blondeau, C. Widmann, M. Lazdunski, and C. Heurteaux, "Activation of the nuclear factor-κB is a key event in brain tolerance, " Journal of Neuroscience, vol. 21, no. 13, pp. 4668-4677, 2001.
12. X. Jiang, F. Tian, Y. Du et al., "BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability, " Journal of Neuroscience, vol. 28, no. 5, pp. 1118-1130, 2008.
13. R. H. Lipsky, K.Xu, D. Zhu et al., "Nuclear factor κB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection, " Journal of Neurochemistry, vol. 78, no. 2, pp. 254-264, 2001.
14. A. M. Marini, S. J. Rabin, R. H. Lipsky, and I. Mocchetti, "Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-Daspartate, " Journal of Biological Chemistry, vol. 273, no. 45, pp. 29394-29399, 1998.
15. X. Jiang, F. Tian, K.Mearow, P. Okagaki, R. H. Lipsky, and A.M. Marini, "The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons, " Journal of Neurochemistry, vol. 94, no. 3, pp. 713-722, 2005.
16. J. M. Bourre, O. Dumont, M. Piciotti et al., "Essentiality of omega 3 fatty acids for brain structure and function, " World Review of Nutrition and Dietetics, vol. 66, pp. 103-117, 1991.
17. M. Hedelin, E. T. Chang, F. Wiklund et al., "Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism, " International Journal of Cancer, vol. 120, no. 2, pp. 398-405, 2007.
18. M. Hughes-Fulford, R. R. Tjandrawinata, C.-F. Li, and S. Sayyah, "Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells, " Carcinogenesis, vol. 26, no. 9, pp. 1520-1526, 2005.
19. J. Shannon, I. B. King, R. Moshofsky et al., "Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China, " The American Journal of Clinical Nutrition, vol. 85, no. 4, pp. 1090-1097, 2007.
20. A. P. Simopoulos, "Omega-3 fatty acids in health and disease and in growth and development, " The American Journal of Clinical Nutrition, vol. 54, no. 3, pp. 438-463, 1991.
21. J. Regnstrom, J. Nilsson, P. Tornvall, C. Landou, and A. Hamsten, "Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis inman, " The Lancet, vol. 339, no. 8803, pp. 1183-1186, 1992.
22. R. Freese, M. Mutanen, L. M. Valsta, and I. Salminen, "Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/α-linolenic acid ratio on platelet aggregation, "Thrombosis and Haemostasis, vol. 71, no. 1, pp. 73-77, 1994.
23. N. G. Bazan, "Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection, " Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 2, pp. 136-141, 2007.
24. N. D. Riediger, R. A. Othman, M. Suh, and M.H.Moghadasian, "A systemic review of the roles of n-3 fatty acids in health and disease, " Journal of the American Dietetic Association, vol. 109, no. 4, pp. 668-679, 2009.
25. K. He, Y. Song, M. L. Daviglus et al., "Accumulated evidence on fish consumption and coronary heart diseasemortality: ametaanalysis of cohort studies, " Circulation, vol. 109, no. 22, pp. 2705-2711, 2004.
26. A. Messori, V. Fadda, D. Maratea, and S. Trippoli, "ω-3 fatty acid supplements for secondary prevention of cardiovascular disease: from"no proof of effectiveness" to "proof of no effectiveness", " JAMA Internal Medicine, vol. 173, no. 15, pp. 1466-1468, 2013.
27. S. M. Kwak, S.-K. Myung, Y. J. Lee, and H. G. Seo, "Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials, " Archives of Internal Medicine, vol. 172, no. 9, pp. 686-694, 2012.
28. R. Marchioli, "Dietary supplementation with N-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial, " The Lancet, vol. 354, no. 9177, pp. 447-455, 1999.
29. M. Yokoyama, H. Origasa, M. Matsuzaki et al., "Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis, " The Lancet, vol. 369, no. 9567, pp. 1090-1098, 2007.
30. R. M. Krauss, R. H. Eckel, B. Howard et al., "AHA Dietary Guidelines Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association, " Circulation, vol. 102, no. 18, pp. 2284-2299, 2000.
31. N. J. Stone, "Fish consumption, fish oil, lipids, and coronary heart disease, " Circulation, vol. 94, no. 9, pp. 2337-2340, 1996.
32. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, "Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, " Circulation, vol. 106, no. 21, pp. 2747-2757, 2002.
33. J. C. Stanley, R. L. Elsom, P. C. Calder et al., "UK Food Standards AgencyWorkshop Report: the effects of the dietary n-6:n-3 fatty acid ratio on cardiovascular health, " British Journal of Nutrition, vol. 98, no. 6, pp. 1305-1310, 2007.
34. A. P. Simopoulos, "Overview of evolutionary aspects of omega 3 fatty acids in the diet, " World Review of Nutrition and Dietetics, vol. 83, pp. 1-11, 1998.
35. D. Rodriguez-Leyva, C. M. C. Bassett, R. McCullough, and G. N. Pierce, "The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid, " Canadian Journal of Cardiology, vol. 26, no. 9, pp. 489-496, 2010.
36. J.-M. Bourre, "Where to find omega-3 fatty acids and how feeding animals with diet enriched in omega-3 fatty acids to increase nutritional value of derived products for human: what is actually useful?" Journal of Nutrition, Health and Aging, vol. 9, no. 4, pp. 232-242, 2005.
37. G. Barceló-Coblijn and E. J. Murphy, "Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels, " Progress in Lipid Research, vol. 48, no. 6, pp. 355-374, 2009.
38. J. T. Brenna, N. Salem Jr., A. J. Sinclair, and S. C. Cunnane, "α-linolenic acid supplementation and conversion to n-3 longchain polyunsaturated fatty acids in humans, " Prostaglandins Leukotrienes and Essential FattyAcids, vol. 80, no. 2-3, pp.85-91, 2009.
39. W. E. Connor, "Importance of n-3 fatty acids in health and disease, " The American Journal of Clinical Nutrition, vol. 71, supplement 1, pp. 171S-175S, 2000.
40. D. Richard, P. Bausero, C. Schneider, and F. Visioli, "Poly unsaturated fatty acids and cardiovascular disease, " Cellular and Molecular Life Sciences, vol. 66, no. 20, pp. 3277-3288, 2009.
41. C. R. Harper, M. C. Edwards, and T. A. Jacobson, "Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjects, " Journal of Nutrition, vol. 136, no. 11, pp. 2844-2848, 2006.
42. C.R.Harper, M. J. Edwards, A. P. DeFilipis, and T.A. Jacobson, "Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans, " Journal of Nutrition, vol. 136, no. 1, pp. 83-87, 2006.
43. F. Fuentes, J. López-Miranda, P. Pérez-Martínez et al., "Chronic effects of a high-fat diet enriched with virgin olive oil and a lowfat diet enriched with α-linolenic acid on postprandial endothelial function in healthy men, " British Journal of Nutrition, vol. 100, no. 1, pp. 159-165, 2008.
44. J. H. Christensen, M. S. Christensen, E. Toft, J. Dyerberg, and E. B. Schmidt, "α-linolenic acid and heart rate variability, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 10, no. 2, pp. 57-61, 2000.
45. C. R. Harper and T. A. Jacobson, "Usefulness of omega-3 fatty acids and the prevention of coronary heart disease, " The American Journal of Cardiology, vol. 96, no. 11, pp. 1521-1529, 2005.
46. M. De Lorgeril, S. Renaud, N. Mamelle et al., "Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease, " The Lancet, vol. 343, no. 8911, pp. 1454-1459, 1994.
47. M. de Lorgeril, P. Salen, J.-L.Martin, I.Monjaud, J. Delaye, and N. Mamelle, "Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications aftermyocardial infarction: final report of the Lyon Diet Heart Study, " Circulation, vol. 99, no. 6, pp. 779-785, 1999.
48. F. B. Hu, M. J. Stampfer, J. E. Manson et al., "Dietary intake of α-linolenic acid and risk of fatal ischemic heart disease among women, "The American Journal of Clinical Nutrition, vol. 69, no. 5, pp. 890-897, 1999.
49. E. Wendland, A. Farmer, P. Glasziou, and A. Neil, "Effect of α linolenic acid on cardiovascular risk markers: a systematic review, " Heart, vol. 92, no. 2, pp. 166-169, 2006.
50. D. Richard, K. Kefi, U. Barbe, P. Bausero, and F. Visioli, "Polyunsaturated fatty acids as antioxidants, " Pharmacological Research, vol. 57, no. 6, pp. 451-455, 2008.
51. E. Vericel, A. Polette, S. Bacot, C. Calzada, and M. Lagarde, "Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets, " Journal of Thrombosis and Haemostasis, vol. 1, no. 3, pp. 566-572, 2003.
52. T. A.Mori and L. J. Beilin, "Omega-3 fatty acids and inflammation, " Current Atherosclerosis Reports, vol. 6, no. 6, pp. 461-467, 2004.
53. F. M. van der Valk, D. F. van Wijk, and E. S. G. Stroes, "Novel anti-inflammatory strategies in atherosclerosis, " Current Opinion in Lipidology, vol. 23, no. 6, pp. 532-539, 2012.
54. J. de Goede, W. M. M. Verschuren, J.M. A. Boer, D. Kromhout, and J. M. Geleijnse, "Alpha-linolenic acid intake and 10-year incidence of coronary heart disease and stroke in 20, 000 middle-aged men and women in the Netherlands, " PLoS ONE, vol. 6, no. 3, Article ID e17967, 2011.
55. M. A. Moskowitz, E. H. Lo, and C. Iadecola, "The science of stroke:mechanisms in search of treatments, " Neuron, vol. 67, no. 2, pp. 181-198, 2010.
56. N. Blondeau, O. Pétrault, S. Manta et al., "Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel, " Circulation Research, vol. 101, no. 2, pp. 176-184, 2007.
57. N. Blondeau, C. Widmann, M. Lazdunski, and C. Heurteaux, "Polyunsaturated fatty acids induce ischemic and epileptic tolerance, " Neuroscience, vol. 109, no. 2, pp. 231-241, 2002.
58. C. Heurteaux, N. Guy, C. Laigle et al., "TREK-1, a K+ channel involved in neuroprotection and general anesthesia, "TheEMBO Journal, vol. 23, no. 13, pp. 2684-2695, 2004.
59. C. Heurteaux, C. Laigle, N. Blondeau, G. Jarretou, and M. Lazdunski, "Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia, " Neuroscience, vol. 137, no. 1, pp. 241-251, 2006.
60. L. Lang-Lazdunski, N. Blondeau, G. Jarretou, M. Lazdunski, and C. Heurteaux, "Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats, " Journal of Vascular Surgery, vol. 38, no. 3, pp. 564-575, 2003.
61. I. Lauritzen, N. Blondeau, C. Heurteaux, C. Widmann, G. Romey, and M. Lazdunski, "Polyunsaturated fatty acids are potent neuroprotectors, " The EMBO Journal, vol. 19, no. 8, pp. 1784-1793, 2000.
62. + channel, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 5, pp. 2680-2685, 1998.
63. J.A. Simon, J. Fong, J. T. Bernert Jr., and W. S. Browner, "Serum fatty acids and the risk of stroke, " Stroke, vol. 26, no. 5, pp. 778-782, 1995.
64. L. Djoussé, S. C. Hunt, D. K. Arnett, M. A. Province, J. H. Eckfeldt, and R. C. Ellison, "Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study, " The American Journal of Clinical Nutrition, vol. 78, no. 6, pp. 1098-1102, 2003.
65. + channel stimulated by arachidonic acid and polyunsaturated fatty acids, " The EMBO Journal, vol. 17, no. 12, pp. 3297-3308, 1998.
66. J. S. Tauskela and N. Blondeau, "Prescription for stroke: should preconditioning be investigated as a drug?" in Ischemic Tolerance of the Brain, Research Signpost, B. J. Schaller, Ed., pp. 85-135, Research Signpost, Kerala, India, 2009.
67. M. M. Hofer and Y.-A. Barde, "Brain-derived neurotrophic factor prevents neuronal death in vivo, " Nature, vol. 331, no. 6153, pp. 261-262, 1988.
68. J. Lee, W. Duan, and M. P. Mattson, "Evidence that brainderived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice, " Journal of Neurochemistry, vol. 82, no. 6, pp. 1367-1375, 2002.
69. B. Lu and A. Figurov, "Role of neurotrophins in synapse development and plasticity, " Reviews in the Neurosciences, vol. 8, no. 1, pp. 1-12, 1997.
70. A. M.Marini, X. Jiang, X.Wu et al., "Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli, " Amino Acids, vol. 32, no. 3, pp. 299-304, 2007.
71. M. P. Mattson, W. Duan, and Z. Guo, "Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular andmolecularmechanisms, " Journal of Neurochemistry, vol. 84, no. 3, pp. 417-431, 2003.
72. Q. Yan, R. D. Rosenfeld, C. R. Matheson et al., "Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system, " Neuroscience, vol. 78, no. 2, pp. 431-448, 1997.
73. D. D. Mosser, A. W. Caron, L. Bourget et al., "The chaperone function of hsp70 is required for protection against stressinduced apoptosis, " Molecular and Cellular Biology, vol. 20, no. 19, pp. 7146-7159, 2000.
74. P. C. Calder, "Mechanisms of action of (n-3) fatty acids, " Journal of Nutrition, vol. 142, no. 3, pp. 592S-599S, 2012.
75. A. H. Nagahara and M. H. Tuszynski, "Potential therapeutic uses of BDNF in neurological and psychiatric disorders, " Nature Reviews Drug Discovery, vol. 10, no. 3, pp. 209-219, 2011.
76. Y. Jiang, N.Wei, T. Lu, J. Zhu, G. Xu, and X. Liu, "Intranasal brain-derived neurotrophic factor protects brain fromischemic insult via modulating local inflammation in rats, " Neuroscience, vol. 172, pp. 398-405, 2011.
77. H. D. Müller, K. M. Hanumanthiah, K. Diederich, S. Schwab, W.-R. Schäbitz, and C. Sommer, "Brain-derived neurotrophic factor but not forced armuse improves long-termoutcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain, " Stroke, vol. 39, no. 3, pp. 1012-1021, 2008.
78. E. Larsson, A. Nanobashvili, Z. Kokaia, and O. Lindvall, "Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats, " Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 11, pp. 1220-1228, 1999.
79. W. R. Schabitz, S. Schwab, M. Spranger, and W. Hacke, "Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats, " Journal of Cerebral Blood Flow and Metabolism, vol. 17, no. 5, pp. 500-506, 1997.
80. W.-R. Schabitz, C. Sommer, W. Zoder et al., "Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia, " Stroke, vol. 31, no. 9, pp. 2212-2217, 2000.
81. D. Wu, "Neuroprotection in experimental stroke with targeted neurotrophins, " NeuroRx, vol. 2, no. 1, pp. 120-128, 2005.
82. N. Blondeau, C. Nguemeni, D. N. Debruyne et al., "Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke, " Neuropsychopharmacology, vol. 34, no. 12, pp. 2548-2559, 2009.
83. C.Capone, S. Frigerio, S.Fumagalli et al., "Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment, " PLoS ONE, vol. 2, no. 4, article e373, 2007.
84. S.Maysami, J. Q. Lan, M.Minami, and R. P. Simon, "Proliferating progenitor cells: a required cellular element for induction of ischemic tolerance in the brain, " Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 6, pp. 1104-1113, 2008.
85. Y. Moriyama, N. Takagi, and K. Tanonaka, "Intravenous injection of neural progenitor cells improved depression-like behavior after cerebral ischemia, " Translational Psychiatry, vol. 1, article e29, 2011.
86. T. Nomura, O. Honmou, K. Harada, K. Houkin, H. Hamada, and J. D. Kocsis, "I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat, " Neuroscience, vol. 136, no. 1, pp. 161-169, 2005.
87. R. Pallini, L. R. Vitiani, A. Bez et al., "Homologous transplantation of neural stem cells to the injured spinal cord of mice, " Neurosurgery, vol. 57, no. 5, pp. 1014-1024, 2005.
88. B. Fure, T. B. Wyller, K. Engedal, and B. Thommessen, "Emotional symptoms in acute ischemic stroke, " International Journal of Geriatric Psychiatry, vol. 21, no. 4, pp. 382-387, 2006.
89. M. Lucas, F. Mirzaei, E. J. O"Reilly et al., "Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study, " The American Journal of Clinical Nutrition, vol. 93, no. 6, pp. 1337-1343, 2011.
90. J. R. Hibbeln, "Fish consumption and major depression, " The Lancet, vol. 351, no. 9110, p. 1213, 1998.
91. M. Peet, B. Murphy, J. Shay, and D. Horrobin, "Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients, " Biological Psychiatry, vol. 43, no. 5, pp. 315-319, 1998.
92. M. Peet and C. Stokes, "Omega-3 fatty acids in the treatment of psychiatric disorders, " Drugs, vol. 65, no. 8, pp. 1051-1059, 2005.
93. V. R. Venna, D. Deplanque, C. Allet, K. Belarbi, M. Hamdane, and R. Bordet, "PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus, " Psychoneuroendocrinology, vol. 34, no. 2, pp. 199-211, 2009.
94. D. Soppet, E. Escandon, J. Maragos et al., "The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor, " Cell, vol. 65, no. 5, pp. 895-903, 1991.
95. E. Koponen, T. Rantamaki, V. Voikar, T. Saarelainen, E. MacDonald, and E. Castren, "Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines, " Cellular and Molecular Neurobiology, vol. 25, no. 6, pp. 973-980, 2005.
96. I. A. Kerman, "New insights into BDNF signaling: relevance to major depression and antidepressant action, " American Journal of Psychiatry, vol. 169, no. 11, pp. 1137-1140, 2012.
97. A. T. Michael-Titus, "Omega-3 fatty acids and neurological injury, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 77, no. 5-6, pp. 295-300, 2007.
98. A. R. Heller, S. Rössler, R. J. Litz et al., "Omega-3 fatty acids improve the diagnosis-related clinical outcome, " Critical Care Medicine, vol. 34, no. 4, pp. 972-979, 2006.
99. A. Martin, "The "apports nutritionnels conseilles (ANC)" for the French population, " Reproduction Nutrition Development, vol. 41, no. 2, pp. 119-128, 2001.